Subtitle
QoL and Patient-Reported Outcomes Following PT.
This systematic review reported that PBT provides favorable QOL/PRO profiles for select brain, head/neck, lung, and pediatric cancers; measures for prostate and breast cancers were more modest.
These results have implications for cost-effective cancer care and prudently designed QOL evaluation in ongoing trials.